ALOK JAIN: Open Payments
NPI 1285630095 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$11,936 in 137 payments from 15 companies in 2025. Trend: 2023 $1,247 · 2024 $976 · 2025 $11,936
Consulting: $8,395Food & beverage: $2,221Travel & lodging: $1,316Education: $4
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 57 | $10,515 |
| Alkermes, Inc. | 15 | $311 |
| Corium, LLC | 8 | $230 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $212 |
| Neurocrine BioSciences, Inc. | 12 | $173 |
| Teva Pharmaceuticals USA, Inc. | 8 | $139 |
| Janssen Pharmaceuticals, Inc | 5 | $93 |
| ABBVIE INC. | 3 | $56 |
| Vanda Pharmaceuticals Inc. | 3 | $53 |
| Lundbeck LLC | 3 | $47 |
Products named: COBENFY, ARISTADA, Azstarys, CAPLYTA, INGREZZA, UZEDY, SPRAVATO, VRAYLAR.
Industry payments across MO — which companies pay providers there.
